To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Ara Parseghian Medical Research Foundation


4729 E Sunrise Dr.
Suite 327
Tucson, AZ 85718-4535 USA





Email Address

[email protected]


The Ara Parseghian Medical Research Foundation (APMRF) is an international, non-profit, voluntary organization dedicated to funding research projects to expedite a cure for Niemann-Pick disease type C (NP-C); promoting collaborative research efforts among experts in cholesterol metabolism; and studying parallel pediatric neurodegenerative disorders. NP-C, a rare inherited disorder of childhood, is a degenerative disease that causes progressive deterioration of the nervous system due to an inability to properly break down cholesterol. Excessive amounts of cholesterol accumulate in the brain, liver, and spleen leading to a variety of symptoms and findings. These may include abnormal enlargement of the liver and spleen (hepatosplenomegaly); difficulty walking (ataxia) and positioning the arms and legs; slurred or slow speech; difficulties performing certain eye movements (vertical supranuclear gaze palsy); and additional symptoms. During mid-adolescence, progressive neurological problems usually lead to life-threatening complications. The foundation's purpose is to speed the search for a cure by funding research and promoting worldwide interaction among scientists, research institutes, universities and pharmaceutical companies working on NP-C and related diseases.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.